Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleyl Sulfate SCHEMBL430289 | 1.00 | CNR2 (0.42) | CNR2TRPV1CNR1FAAHLPAR1 | |
| Trolamine SCHEMBL10948957 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Octadecyl Sulfate SCHEMBL3963772 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Trolamine SCHEMBL10612409 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Trolamine SCHEMBL2324894 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Trolamine SCHEMBL3656221 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Trolamine SCHEMBL430868 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Trolamine SCHEMBL2323494 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Trolamine SCHEMBL9481005 | 0.91 | CA1 (0.47) | CA1CA2CA9 | |
| Trolamine SCHEMBL378933 | 0.91 | CA1 (0.47) | CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3610849-B1 | METHOD FOR REMOVING KERATOTIC PLUGS | KAO CORP (JP) | 2025-09-17 | — | — | EP | disclosed |
| EP-4023304-B1 | A KERATOTIC PLUG-REMOVING COMPOSITION | KAO CORP (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-3610848-B1 | SKIN CLEANSING COMPOSITION | KAO CORP (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-11975086-B2 | Method for removing keratotic plugs | KAO CORPORATION (JP) | 2024-05-07 | — | — | US | disclosed |
| US-20240099955-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | HTL BIOTECHNOLOGY INNOVATION INC. | 2024-03-28 | — | — | US | disclosed |
| EP-4288084-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | Modern Meadow, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-4269549-A2 | SKIN CLEANSING COMPOSITIONS | Kao Corporation (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-3610850-B1 | SKIN CLEANSING COMPOSITIONS | KAO CORP (JP) | 2023-10-25 | — | — | EP | disclosed |
| CN-116847871-A | Skin care compositions and methods of use | 现代牧场股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116785188-A | Skin cleansing composition | 花王株式会社 | 2023-09-22 | — | — | CN | disclosed |
| US-20050220744-A1 | Polysaccharide/functional compound complex | SHOWA DENKO K.K. | 2005-10-06 | — | — | US | disclosed |
| WO-2005089708-A1 | OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005034903-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | SHOWA DENKO K.K. (JP) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005020950-A1 | COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE | SHOWA DENKO K.K. (JP) | 2005-03-10 | — | — | WO | disclosed |
| US-5468650-A | Glass, allery diagnosis | A/S LUNDBECK EXPORT DIVISION LTD. (DK) | 1995-11-21 | — | — | US | disclosed |
| EP-0428606-B1 | METHOD AND MEANS FOR ALLERGY DIAGNOSIS | ALLERGIFONDEN AF 1981 (DK) | 1994-10-19 | — | — | EP | disclosed |
| US-5098831-A | Histamine is bound with a binder such as an organic polymer and quantitative detection of the histamne present | ALLERGIFONDEN AF 1981 (DK) | 1992-03-24 | — | — | US | disclosed |
| EP-0428606-A1 | METHOD AND MEANS FOR ALLERGY DIAGNOSIS. | ALLERGIFONDEN AF 1981 (DK) | 1991-05-29 | — | — | EP | disclosed |
| WO-1990001699-A1 | METHOD AND MEANS FOR ALLERGY DIAGNOSIS | ALLERGIFONDEN AF 1981 (DK) | 1990-02-22 | — | — | WO | disclosed |
| EP-0354799-A1 | Method and means for allergy diagnosis | LUNDBECK DIAGNOSTICS A/S (DK) | 1990-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11975086-B2 | Method for removing keratotic plugs | PAM, MUC1, CUTA | CNR2 450/4885TRPV1 2277/4885CNR1 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.